Use Able AI chat for product recommendations

CYP2D6/7 Polyclonal antibody

CYP2D6/7 Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF, ELISA

CYP2D6, Cholesterol 25-hydroxylase, CYP2DL1, CYPIID6, Cytochrome P450 2D6

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for CYP2D6/7 in ?

Tested Applications

Positive WB detected inmouse liver tissue, rat liver tissue
Positive IHC detected inhuman liver cancer tissue, human liver tissue, human kidney tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:12000
Immunohistochemistry (IHC)IHC : 1:200-1:600
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

17868-1-AP targets CYP2D6/7 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag12351

Product name: Recombinant human CYP2D6 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 148-497 aa of BC075023

Sequence: SLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPR

Predict reactive species
Full Name cytochrome P450, family 2, subfamily D, polypeptide 6
Calculated Molecular Weight 497 aa, 56 kDa
Observed Molecular Weight 48-56 kDa
GenBank Accession NumberBC075023
Gene Symbol CYP2D6
Gene ID (NCBI) 1565
RRIDAB_2878457
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP10635
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

CYP2D6(Cytochrome P450 2D6) is also named as CYP2DL1 and belongs to the cytochrome P450 family. It is a monooxygenase that involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants. CYP2D6 is responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It has 2 isoforms produced by alternative splicing with the molecular weight of 56 kDa and 50 kDa. This antibody can recognize human CYP2D6/7, mouse CYP2D3/4/9/10/22/26, rat CYP2D1/3/4/10/26, due to the high homology.

Protocols

Product Specific Protocols
IHC protocol for CYP2D6/7 antibody 17868-1-APDownload protocol
WB protocol for CYP2D6/7 antibody 17868-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The CYP2D6/7 Polyclonal antibody (Cat# 17868-1-AP) has 14 citations published in journals including J Adv Res, Theranostics, Biochem Pharmacol, Eur J Pharm Sci, Sci Rep, Drug Metab Dispos, J Ethnopharmacol, Drug Des Devel Ther, J Pharm Biomed Anal, Drug Metab Pharmacokinet, Biol Pharm Bull, Xenobiotica, Pharmazie, and ACS Pharmacol Transl Sci. Research fields span drug metabolism, pharmacokinetics, CYP450-mediated drug interactions, hepatotoxicity screening, and hepatic enzyme expression.

SpeciesApplicationTitle

J Adv Res

Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug

Authors - Jing Guo
humanIHC

Theranostics

Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.

Authors - Zhenyu Wang
ratWB

J Ethnopharmacol

Integrated pharmacokinetic properties, tissue distribution and metabolism of multiple active constituents in DBD for the treatment of GEM-induced myelosuppression.

Authors - Xiaodan Qi

Biochem Pharmacol

Effects of CYP3A4 variants and drug-drug interactions on the metabolism of fexinidazole.

Authors - Jinyu Hu
humanWB

Drug Des Devel Ther

Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG Cells.

Authors - Hongfang Li
humanWB

Eur J Pharm Sci

PMID: 30776468

Authors - Vinay R Sonawane
Loading...
||
New chat

Able™

正在加载,请稍候...